Perfuze, Ltd.
Explore this company’s associated devices, FDA decisions and regulatory history.

Perfuze, Ltd.
- Regulatory records
- 4
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 4 FDA records to the applicant name Perfuze, Ltd.. The collection includes 4 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Mar 16, 2026 to Nov 5, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code NRY appears in 2 of the 4 linked filings. The collection spans 2 FDA product codes. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: Unit 6, Galway Business Park, Dangan, Galway, H91W7CP, IE. Recorded on K261449, decision dated Nov 5, 2026.
Device categories in this collection
Catheter, Percutaneous, Neurovasculature; Catheter, Thrombus Retriever.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
NeuroSheathK261449 | Perfuze, Ltd. | 510(k) clearance | Nov 5, 2026 | FDA |
Millipede SystemK262399 | Perfuze, Ltd. | 510(k) clearance | Aug 12, 2026 | FDA |
Millipede88 Access CatheterK253901 | Perfuze, Ltd. | 510(k) clearance | Jul 9, 2026 | FDA |
Millipede SystemK253590 | Perfuze, Ltd. | 510(k) clearance | Mar 16, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.



